Skip to content
HowShorted

Twist Bioscience Corp short interest in 2021

In 2021, Twist Bioscience Corp's disclosed short interest ran from 5.32% of shares outstanding on 15 Jan 2021 to 9.92% on 31 Dec 2021, a change of +4.60 percentage points. The year's high was 9.99% on 15 Dec 2021 and its low 4.12% on 12 Feb 2021, averaging 7.02% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.35 days on 29 Oct 2021. Full history: Twist Bioscience Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Twist Bioscience Corp in 2021

2021 in figures

Start of year
5.32% (15 Jan 2021)
End of year
9.92% (31 Dec 2021)
Change
+4.60 pp
High
9.99% (15 Dec 2021)
Low
4.12% (12 Feb 2021)
Average
7.02%
Highest days to cover
12.35 (29 Oct 2021)
SEC filings marked
8

Every report in 2021

Twist Bioscience Corp short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20215.32%3.64
29 Jan 20214.13%2.36
12 Feb 20214.12%2.11results (8-K), 10-Q filed
26 Feb 20215.27%2.64
15 Mar 20217.36%3.20
31 Mar 20218.41%3.62
15 Apr 20217.73%5.10
30 Apr 20217.21%8.01
14 May 20218.09%4.17results (8-K), 10-Q filed
28 May 20217.54%6.55
15 Jun 20217.46%7.03
30 Jun 20216.68%5.60
15 Jul 20216.40%8.40
30 Jul 20216.40%7.78
13 Aug 20216.88%7.03results (8-K), 10-Q filed
31 Aug 20216.94%7.11
15 Sep 20216.83%10.07
30 Sep 20216.78%8.00
15 Oct 20217.51%8.18
29 Oct 20216.89%12.35
15 Nov 20216.42%7.40
30 Nov 20218.18%5.20results (8-K), 10-K filed
15 Dec 20219.99%6.45
31 Dec 20219.92%7.67

See also: Twist Bioscience Corp's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.